Among all breast cancer subtypes, human epidermal growth factor receptor 2 (HER2)-positive - and triple-negative (estrogen- and progesterone receptors- and HER2 protein-negative) breast cancers have a higher risk of developing brain metastases [[3], [4], [5], [6]]. This evidence concerns the gene ERBB2 and breast carcinoma.